LSN3154567

Biochem/physiol Actions

LSN3154567 is an orally available, potent and highly selective inhibitor of nicotinamide phosphoribosyltransferase (NAMPT). LSN3154567 exhibits broad spectrum and potent anticancer activities without causing retinopathy in the rat. LSN3154567co-administration with nicotinic acid (NA) produces potent anti-tumor activity in tumor xenograft models without retinal and hematological toxicities.

LSN3154567 might be useful in developing a novel cancer therapeutic.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3576031 LSN3154567 white to beige SIGMA-ALDRICH 2-8°C DMSO: 2 mg/mL, clear
£525.11 (exc VAT) per 25MG
-
+
3576032 LSN3154567 white to beige SIGMA-ALDRICH 2-8°C DMSO: 2 mg/mL, clear
£130.37 (exc VAT) per 5MG
-
+